발행물
컨퍼런스
esc2019
2019
,
Age-dependent anti-thrombotic therapy for atrial fibrillation patients with intermediate risk (CHA2DS2-VASc Score of 1 or 2) of ischemic stroke
Performance of the HAS-BLED, ATRIA, and PRECISE-DAPT Bleeding Risk Scores in Atrial Fibrillation Patients Using Antiplatelet Agents or Oral Anticoagulants
JCS2019
The effects of weather conditions on myocardial infarction incidence
Long-Term Outcomes in Unprotected Left Main Coronary Artery Disease: CABG and PCI at a Korean Center
A Prospective, Randomized, Open-Label, Endpoint Study Exploring Platelet Response to Half-Dose Prasugrel and Ticagrelor in Patients with ACS: HOPE-TAILOR Study